Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Net Sales	$ 1,975.5	$ 2,017.6
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 553.4	$ 575.8
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 143.4	$ 150.8
Research and development	101.7	95.7
Selling, general and administrative	796.4	801.7
Acquisition, integration and related	10.7	46.0
Quality remediation	19.7	42.6
Operating expenses	1,625.3	1,712.6
Operating Profit	350.2	305.0
Other expense, net	(0.5)	(3.6)
Interest expense, net	(58.0)	(78.0)
Earnings before income taxes	291.7	223.4
Provision for income taxes	45.5	47.2
Net Earnings	246.2	176.2
Less: Net earnings attributable to noncontrolling interest	0.1	1.5
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 246.1	$ 174.7
Earnings Per Common Share
Basic	$ 1.20	$ 0.86
Diluted	$ 1.20	$ 0.85
Weighted Average Common Shares Outstanding
Basic	204.4	203.0
Diluted	205.8	204.6